SCHEMBL25375152

SCHEMBL25375152

CC(C)(OCCCl)C(=O)O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 6/20 0.35
CYP2D6 P10635 2/20 0.35
CYP2C19 P33261 2/20 0.35
MEN1 O00255 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35
PPARG P37231 3/20 0.33
TSHR P16473 2/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP4F2 P78329 6/20 0.33
CYP4A11 Q02928 6/20 0.33
PPARD Q03181 1/20 0.33
SLC16A3 O15427 4/20 0.33
HIF1A Q16665 1/20 0.32
SLC16A1 P53985 2/20 0.31
MCTS1 Q9ULC4 2/20 0.31
FABP2 P12104 1/20 0.31
SLC22A12 Q96S37 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7932802 0.80 PPARA (0.41) PPARACYP2D6CYP2C19MEN1CYP1A2
SCHEMBL22609458 0.78 LMNA (0.38) PPARACYP2D6CYP2C19KMT2APPARG
SCHEMBL30997236 0.76 ALDH1A1 (0.37) PPARACYP2D6CYP2C19MEN1CYP1A2
SCHEMBL15105911 0.76 PPARA (0.35) PPARACYP2D6CYP2C19MEN1CYP1A2
SCHEMBL28695124 0.74 CYP4F2 (0.49) PPARACYP2D6CYP2C19MEN1CYP1A2
SCHEMBL3291432 0.74 ALDH1A1 (0.43) PPARAPPARGTSHRALDH1A1CYP4F2
SCHEMBL20254059 0.73 CYP4F2 (0.37) PPARACYP2D6CYP2C19PPARGTSHR
SCHEMBL254199 0.73 CYP4F2 (0.43) PPARAPPARGTSHRCYP4F2CYP4A11
SCHEMBL642729 0.72
SCHEMBL27963285 0.71 CYP4F2 (0.34) PPARACYP2D6CYP2C19MEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230248837-A1 Technology for Modulating Targeting Chimeras Induced by Cell-Penetrating Peptide and Application Thereof LIU, MIAO (CN) 2023-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230248837-A1 Technology for Modulating Targeting Chimeras Induced by Cell-Penetrating Peptide and Application Thereof VIP, GHITM, MYCBP PPARA 3613/4885CYP2D6 3924/4885CYP2C19 4607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.